OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BTEK$12.0055

Bumi Teknokultura Unggul Tbk PT

Food ProcessingVerified

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.36, indicating a significant reliance on debt financing. Despite a negative net income of -24.65 billion IDR, the company maintains a strong liquidity position, with a free cash flow of 22.73 billion IDR. The price-to-book ratio of 0.52 suggests the company is trading at a discount to its book value, potentially signaling undervaluation or financial distress. Profitability metrics are weak, with a return on equity of -2.31% and a return on assets of -0.58%, both significantly below industry norms. The company's operating income is negative at -13.33 billion IDR, and its gross profit margin is only 7.84% of revenue, indicating poor cost control and pricing power. These metrics suggest the company is underperforming relative to its peers in the food processing industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shocks and supply chain disruptions. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. The negative operating income and weak profitability metrics suggest the company is struggling to scale operations or improve margins. The capital expenditure of -16.44 billion IDR indicates a reduction in investment, which may signal a strategic shift or financial constraints. The company faces moderate liquidity risk, with a current ratio of 0.17, indicating a potential inability to meet short-term obligations. The risk assessment highlights a key flag: net cash is negative after subtracting total debt, suggesting a liquidity crunch. The dilution risk is low, with no near-term pressure from share issuance or convertible debt. Recent filings and transcripts do not provide additional insight into the company's strategic direction or operational performance. The absence of recent disclosures limits the ability to assess management's response to financial challenges or market conditions.

30-day price · BTEK-2.00 (-13.3%)
Low$11.00High$16.00Close$13.00As of17 May, 00:00 UTC
Profile
CompanyBumi Teknokultura Unggul Tbk PT
TickerBTEK.JK
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Bumi Teknokultura Unggul Tbk PT operates in the food processing industry, manufacturing and distributing food products to consumers and businesses.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.36, indicating a significant reliance on debt financing. Despite a negative net income of -24.65 billion IDR, the company maintains a strong liquidity position, with a free cash flow of 22.73 billion IDR. The price-to-book ratio of 0.52 suggests the company is trading at a discount to its book value, potentially signaling undervaluation or financial distress. Profitability metrics are weak, with a return on equity of -2.31% and a return on assets of -0.58%, both significantly below industry norms. The company's operating income is negative at -13.33 billion IDR, and its gross profit margin is only 7.84% of revenue, indicating poor cost control and pricing power. These metrics suggest the company is underperforming relative to its peers in the food processing industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shocks and supply chain disruptions. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. The negative operating income and weak profitability metrics suggest the company is struggling to scale operations or improve margins. The capital expenditure of -16.44 billion IDR indicates a reduction in investment, which may signal a strategic shift or financial constraints. The company faces moderate liquidity risk, with a current ratio of 0.17, indicating a potential inability to meet short-term obligations. The risk assessment highlights a key flag: net cash is negative after subtracting total debt, suggesting a liquidity crunch. The dilution risk is low, with no near-term pressure from share issuance or convertible debt. Recent filings and transcripts do not provide additional insight into the company's strategic direction or operational performance. The absence of recent disclosures limits the ability to assess management's response to financial challenges or market conditions.
Key takeaways
  • The company is highly leveraged, with a debt-to-equity ratio of 2.36, indicating significant financial risk.
  • Profitability is weak, with a negative return on equity and return on assets, suggesting poor operational performance.
  • The company's revenue is concentrated in a single segment, increasing exposure to market volatility.
  • Liquidity is a concern, with a current ratio of 0.17 and negative net cash after debt.
  • Growth is uncertain, with no disclosed revenue growth and reduced capital expenditure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$65.86B
Gross profit$5.16B
Operating income-$13.33B
Net income-$24.65B
R&D
SG&A
D&A
SBC
Operating cash flow$61.85B
CapEx-$16.44B
Free cash flow$22.73B
Total assets$4.25T
Total liabilities$3.19T
Total equity$1.07T
Cash & equivalents
Long-term debt$2.52T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$146.94B-$41.56B-$106.51B-$61.37B
FY-3$153.50B-$41.02B-$133.47B-$81.90B
FY-2$196.67B-$40.53B-$114.05B-$134.66B
FY-1$635.63B-$496.55B-$719.27B-$656.43B
FY0$72.02B-$293.41B-$420.42B-$323.16B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$4.17T$1.56T
FY-3$4.14T$1.20T
FY-2$4.06T$1.11T
FY-1$3.89T$462.50B
FY0$3.51T$283.68B$1.03B
PeriodOCFCapExFCFSBC
FY-4$7.65B-$285.5M-$61.37B
FY-3$22.56B-$204.1M-$81.90B
FY-2$138.15B-$66.80B-$134.66B
FY-1$70.96B-$21.77B-$656.43B
FY0-$37.70B-$4.79B-$323.16B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$65.86B-$13.33B-$24.65B$22.73B
FQ-6$244.89B-$758.0M$10.13B$19.96B
FQ-5$190.56B-$51.64B-$693.37B-$643.74B
FQ-4$33.66B-$42.82B-$30.51B-$21.87B
FQ-3$4.89B-$27.48B-$21.09B-$13.85B
FQ-2$23.99B-$20.82B-$8.80B-$1.18B
FQ-1$9.47B-$202.29B-$360.02B-$286.26B
FQ0$4.65B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$4.25T$1.07T
FQ-6$4.12T$1.09T
FQ-5$3.89T$462.50B
FQ-4$3.89T$424.16B
FQ-3$3.80T$410.30B
FQ-2$3.87T$392.11B$1.53B
FQ-1$3.51T$283.68B$1.03B
FQ0$263.06B$13.23B
PeriodOCFCapExFCFSBC
FQ-7$61.85B-$16.44B$22.73B
FQ-6$79.44B-$15.77B$19.96B
FQ-5$70.96B-$21.77B-$643.74B
FQ-4-$26.11B-$710.7M-$21.87B
FQ-3-$25.72B-$2.92B-$13.85B
FQ-2-$29.28B-$4.70B-$1.18B
FQ-1-$37.70B-$4.79B-$286.26B
FQ0-$17.32B
Valuation
Market price$12.00
Market cap$555.33B
Enterprise value$3.08T
P/E
Reported non-GAAP P/E
EV/Revenue46.7
EV/Op income
EV/OCF49.7
P/B0.5
P/Tangible book0.5
Tangible book$1.07T
Net cash-$2.52T
Current ratio0.2
Debt/Equity2.4
ROA-0.6%
ROE-2.3%
Cash conversion-2.5%
CapEx/Revenue-25.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricBTEKActivity
Op margin-20.2%5.6% medp25 2.1% · p75 11.2%bottom quartile
Net margin-37.4%3.9% medp25 0.5% · p75 8.5%bottom quartile
Gross margin7.8%23.3% medp25 14.8% · p75 32.6%bottom quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-25.0%-4.1% medp25 -8.9% · p75 -1.9%bottom quartile
Debt / equity236.0%37.6% medp25 7.2% · p75 84.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 05:32 UTC#f5e557f9
Market quoteclose IDR 11.00 · shares 46.28B diluted
no public URL
2026-05-09 05:32 UTC#eb54c6f8
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 13:54 UTCJob: 0a6bc6c7